GeminIQ Website Logo

Viewing ANNX free

Subscribe for full history, 90+ metrics, screener, watchlist...

Annexon, Inc.

ANNX

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
199175162139132974980157152225133
Available For Sale Securities Debt Securities Curr…
10507649951672632612111133532
Prepaid Expense And Other Assets Current
434444445644
Assets Current
213228242193231268316344374271264169
Restricted Cash Noncurrent
111111111111
Property Plant And Equipment Net
101011111212131314141515
Operating Lease Right Of Use Asset
141515161616171717181818
Other Assets Noncurrent
89995533-0--
Assets
246263278229265303350379406304298204
Liabilities And Stockhold…
Liabilities Current
Accrued Liabilities Current
--------1171010
Accounts Payable Current
1618151812101074455
Operating Lease Liability Current
333333322222
Other Liabilities Current
--------0000
Liabilities Current
383643444134312017131817
Operating Lease Liability Noncurrent
222223242526262728292930
Liabilities
605866686659574745424747
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital
1,2031,1661,1291,0311,0131,0091,004993988860823702
Accumulated Other Comprehensive Income Loss Net Of…
-0-0-0-0-0-000-0-0-0-0
Retained Earnings Accumulated Deficit
-1,017-962-917-869-814-765-711-662-627-598-572-545
Stockholders Equity
186205212161199244293332361262251157
Liabilities And Stockholders Equity
246263278229265303350379406304298204
Common Stock Par Or Stated Value Per Share
--0.001---0.001---0.001-
Common Stock Shares Authorized
--300---300---300-
Common Stock Shares Issued
--149---109---78-
Shares Outstanding
--149---109---78-

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-1.81%-0.72%-5.43%---------
202546.89%63.28%38.42%-8.82%34.03%32.77%54.70%57.38%109.40%18.55%7.06%-1.21%
202417.86%-7.80%22.59%2.50%12.12%29.77%-19.43%-14.53%-39.34%-5.86%-21.34%-11.72%
2023------17.26%104.87%78.32%-33.72%-37.06%-18.31%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
5.53
6.35
5.68
4.42
5.67
7.99
10.37
17.18
21.81
20.62
14.72
9.85
Quick Ratio
5.44
6.26
5.59
4.33
5.59
7.86
10.23
16.97
21.50
20.17
14.49
9.63
Working Capital
174.28M
192.33M
199.56M
149.24M
189.98M
234.62M
285.95M
324.25M
356.82M
257.61M
245.93M
152.00M
Leverage & Debt
Debt to Equity
0.32
0.29
0.31
0.42
0.33
0.24
0.19
0.14
0.12
0.16
0.19
0.30
Debt Ratio
0.24
0.22
0.24
0.30
0.25
0.20
0.16
0.12
0.11
0.14
0.16
0.23
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Per Share Metrics
Diluted EPS TTM
-1.01
-1.02
-1.34
-1.40
-1.27
-1.13
-1.01
-0.84
-0.88
-0.98
-1.77
-1.87
Free Cash Flow Per Share TTM
-0.98
-0.94
-1.20
-0.85
-0.72
-0.94
-0.86
-0.75
-0.78
-0.95
-1.61
-1.66
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Growth Metrics
Net Income Growth (1Y)
7.36%
18.49%
50.90%
77.77%
63.93%
38.63%
2.95%
-16.51%
-19.64%
-16.88%
-5.43%
-2.90%
EPS Growth (1Y)
-20.78%
-9.63%
33.68%
66.81%
43.83%
14.82%
-43.30%
-55.05%
-53.54%
-49.96%
-31.67%
-11.52%
Valuation Metrics
P/E TTM
-5.66
-5.42
-3.73
-2.18
-1.89
-1.71
-5.10
-7.05
-5.54
-7.28
-2.56
-1.26
P/B TTM
6.17
5.26
3.68
2.82
1.79
1.17
2.40
2.50
1.77
3.35
1.37
1.13
Market Cap
1.15B
1.08B
778.63M
454.83M
355.97M
285.85M
704.88M
828.40M
637.65M
879.57M
343.56M
177.81M
Enterprise Value
947.43M
899.63M
615.55M
314.38M
222.65M
187.70M
654.35M
747.83M
479.32M
726.59M
117.41M
43.62M
Calculated Values
Free Cash Flow TTM
-196.55M
-183.28M
-186.61M
-126.58M
-106.25M
-139.88M
-118.02M
-105.48M
-101.94M
-116.64M
-121.50M
-125.44M
Net Debt
-200.30M
-176.24M
-163.08M
-140.45M
-133.32M
-98.15M
-50.53M
-80.57M
-158.34M
-152.97M
-226.14M
-134.19M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-05-28Purchase
Owner: Satter, Muneer A
Title: -
Shares: 613,497
Price/Share: $5.41
Value: $3,319,018.77
Shares Owned: 10,342,134
Relationship: Director
Ownership: Indirect
2026-05-11Purchase
Owner: Carson, William H.
Title: -
Shares: 8,000
Price/Share: $5.78
Value: $46,240.00
Shares Owned: 78,405
Relationship: Director
Ownership: Direct
2026-04-10Purchase
Owner: Carson, William H.
Title: -
Shares: 8,000
Price/Share: $6.20
Value: $49,600.00
Shares Owned: 70,405
Relationship: Director
Ownership: Direct
2026-03-10Purchase
Owner: Carson, William H.
Title: -
Shares: 8,000
Price/Share: $5.67
Value: $45,360.00
Shares Owned: 62,405
Relationship: Director
Ownership: Direct
2026-03-02Sale
Owner: Dananberg, Jamie
Title: CHIEF MEDICAL OFFICER
Shares: 5,820
Price/Share: $5.43
Value: $31,602.60
Shares Owned: 123,582
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
79.38%
Inst. Shares: 154,159,862
Shares Outstanding: 194,200,100
2025-12-31
87.34%
Inst. Shares: 135,474,925
Shares Outstanding: 155,105,832
2025-09-30
67.15%
Inst. Shares: 100,135,718
Shares Outstanding: 149,123,701
2025-06-30
66.01%
Inst. Shares: 97,909,078
Shares Outstanding: 148,320,803
2025-03-31
66.24%
Inst. Shares: 98,100,606
Shares Outstanding: 148,108,809

Annexon, Inc. (ANNX) — SEC Financial Statements & Analysis

Annexon, Inc. (ANNX) is a pharmaceutical preparations company, incorporated in DE. Annexon, Inc. trades on Nasdaq as: ANNX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Annexon, Inc. reported a Debt-to-Equity ratio of 0.32x, a Price-to-Book (P/B) ratio of 6.17x (TTM), at a market cap of $1.15B. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
0.32x
P/B TTM
6.17x
Market Cap
$1.15B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Annexon, Inc. in?

Annexon, Inc. (ANNX) operates in the Pharmaceutical Preparations industry.

What is ANNX's market cap?

Annexon, Inc. (ANNX) has a market capitalization of $1.15B as of 2026-06-30.

What exchange does ANNX trade on?

Annexon, Inc. (ANNX) trades on the Nasdaq.

Where is Annexon, Inc. incorporated?

Annexon, Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.